Showing results (201-210 of 219) with videos related to
Sort By:
Pageof 22
Blood|April 7, 2021
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 resultsBijal D Shah, Michael R Bishop, Olalekan O Oluwole, et al.American Journal of Human Genetics|August 19, 2007
Evidence of still-ongoing convergence evolution of the lactase persistence T-13910 alleles in humansNabil Sabri Enattah, Aimee Trudeau, Ville Pimenoff, et al.Familial Cancer|May 5, 2020
MLH1 intronic variants mapping to + 5 position of splice donor sites lead to deleterious effects on RNA splicingTamara Alejandra Piñero, Omar Soukarieh, Marion Rolain, et al.The Lancet. Oncology|December 7, 2018
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trialFrederick L Locke, Armin Ghobadi, Caron A Jacobson, et al.Minerva Gastroenterology|March 1, 2023
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndromeGiulia Fiorini, Ilaria M Saracino, Matteo Pavoni, et al.The New England Journal of Medicine|December 12, 2017
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell LymphomaSattva S Neelapu, Frederick L Locke, Nancy L Bartlett, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative StudyJae-Gahb Park, Duck-Woo Kim, Chang Won Hong, et al.BMC Cancer|September 7, 2017
A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin AmericaBenedito Mauro Rossi, Edenir Inêz Palmero, Francisco López-Kostner, et al.Journal for Immunotherapy of Cancer|July 6, 2019
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshopDavide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, et al.Journal for Immunotherapy of Cancer|May 23, 2019
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshopDavide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, et al.Pageof 22